Arkema SA (OTCMKTS:ARKAY – Get Free Report) has been given a consensus rating of “Reduce” by the eight brokerages that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on the company.
Several equities analysts have commented on the stock. Kepler Capital Markets cut shares of Arkema from a “strong-buy” rating to a “hold” rating in a research report on Friday. Zacks Research lowered Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft cut Arkema from a “buy” rating to a “hold” rating in a research report on Monday, November 24th. Barclays lowered Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 11th. Finally, The Goldman Sachs Group upgraded Arkema from a “hold” rating to a “buy” rating in a research note on Tuesday, February 10th.
Check Out Our Latest Stock Report on Arkema
Arkema Stock Up 0.4%
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
See Also
- Five stocks we like better than Arkema
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
